Activated coagulation and fibrinolytic system in cancer patients is associated with tumor
stroma formation and metastasis in different cancer types. The aim of this study is to explore …

Thrombosis is one of the leading causes of mortality in cancer patients. The aim of the study
was to evaluate the concentrations and activities of selected haemostatic parameters in the …

Purpose Activated coagulation and fibrinolytic system in cancer patients is associated with
tumor stroma formation and metastasis in different cancer types. The aim of this study is to …

Background: Coagulation abnormalities such as thrombosis and disseminated intravascular
coagulation (DIC) are the major factors that play a major role in breast cancer. In this study …

Cancer is often associated with abnormal activation of coagulation leading to a
prothrombotic state. Some chemotherapeutic agents used for cancer may induce thrombosis …

Activation of coagulation and fibrinolysis is frequently encountered among cancer patients.
Such tumors are supposed to be associated with higher risk of invasion, metastases and …

Purpose Activation of coagulation and fibrinolysis is frequently found among cancer patients.
Such tumors are considered to be associated with a higher risk of invasion, metastases, and …

Background In breast cancer patients routine thromboprophylaxis is not recommended but
individualized risk assessment is encouraged. The incorporation of hypercoagulability …

Background Tumor stroma, of which fibroblasts are the most abundant cell, resembles a non‐
healing wound, where a procoagulant environment creates a permissive milieu for cancer …

Background The procoagulant phenotype in cancer is linked to thrombosis, cancer
progression, and immune response. A novel treatment that reduces the risk of both …